FULL EVENT GUIDE

Grab Your Copy of the Brand New Agenda for 3rd Molecular Glue Drug Development Summit

The 3rd Molecular Glue Drug Development Summit is returning to bring together leaders across biopharma covering the depth and breadth of the molecular glue field from rational discovery to improving toxicity, PKPD, and late-stage development. Don’t miss out on the unparallel learning and networking opportunities on offer at this summit and join 90+ pioneering Directors, Vice Presidents, and Heads of Medicinal Chemistry, Structural Biology, and Drug Discovery to kickstart your 2025 R&D and fast-track your glues to patients in need faster.

Explore the Full Event Guide to Discover:

  • The full speaker faculty and in-depth session details offering actionable solutions for your molecular glue challenges
  • Unparalleled networking opportunities with glue leaders like AstraZeneca, Asha Therapeutics, Neomorph and more
  • How to access the best available rates and discounts to gain the most value from your attendance

Having trouble downloading the brochure?
Let us know here and we’ll email it to you instead.

Molecular Glue Drug Development 2025 Attendees: Pfizer, Proxygen, Plexium, GSK, Astrazeneca